Frederick Telling

Track

Insider profile

Currently holds a position at Oragenics Inc

Performance

Overall performance
2.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
12 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -92%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Chairman of the Board Oragenics Inc Feb. 4, 2011 -
Frederick Telling's trades of Oragenics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
423.01
Quantity 26,080 +6.7%
Value US$1,069,808
US Oragenics Inc (OGEN)
Transaction date
Proposed sale
Price
250.00
Quantity 40,696
Value US$4,281,585
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
130.36
Quantity 77,211 -8.0%
Value US$1,586,276
US Oragenics Inc (OGEN)
Transaction date
Proposed sale
Price
0.36
Quantity 3,597
Value US$1,294
US Oragenics Inc (OGEN)
Transaction date
Sale
Price
3.57
Quantity 3,500 -8.4%
Value US$12,488
US Oragenics Inc (OGEN)
Transaction date
Proposed sale
Price
3.58
Quantity 3,500
Value US$12,530
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.29
Quantity 10,084 +1.0%
Value US$2,884
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.29
Quantity 78,673 +8.5%
Value US$22,776
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.29
Quantity 3,500 +0.4%
Value US$1,004
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.28
Quantity 65,718 +7.7%
Value US$18,638
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.28
Quantity 56,806 +7.1%
Value US$15,945
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.26
Quantity 15,303 +2.0%
Value US$3,994
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.35
Quantity 59,053 +8.2%
Value US$20,769
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.36
Quantity 124,785 +20.9%
Value US$45,284
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.37
Quantity 100,000 +29.5%
Value US$37,000
US Oragenics Inc (OGEN)
Transaction date
Purchase
Price
0.00
Quantity 100,000
Value US$0
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-15 2025-12-12
US Oragenics Inc (OGEN)
S Sale
26,080 +6.7%
423.01
US$1,069,808 		26,080 +6.7% 423.01 US$1,069,808
2025-12-12 2025-12-12
US Oragenics Inc (OGEN)
PrS Proposed sale
40,696
250.00
US$4,281,585 		40,696 250.00 US$4,281,585
2024-12-09 2024-12-06
US Oragenics Inc (OGEN)
S Sale
77,211 -8.0%
130.36
US$1,586,276 		77,211 -8.0% 130.36 US$1,586,276
2024-12-06 2024-12-06
US Oragenics Inc (OGEN)
PrS Proposed sale
3,597
0.36
US$1,294 		3,597 0.36 US$1,294
2023-12-01 2023-11-30
US Oragenics Inc (OGEN)
S Sale
3,500 -8.4%
3.57
US$12,488 		3,500 -8.4% 3.57 US$12,488
2023-11-30 2023-11-30
US Oragenics Inc (OGEN)
PrS Proposed sale
3,500
3.58
US$12,530 		3,500 3.58 US$12,530
2022-06-21 2022-06-17
US Oragenics Inc (OGEN)
B Purchase
10,084 +1.0%
0.29
US$2,884 		10,084 +1.0% 0.29 US$2,884
2022-05-25 2022-05-24
US Oragenics Inc (OGEN)
B Purchase
78,673 +8.5%
0.29
US$22,776 		78,673 +8.5% 0.29 US$22,776
2022-05-25 2022-05-23
US Oragenics Inc (OGEN)
B Purchase
3,500 +0.4%
0.29
US$1,004 		3,500 +0.4% 0.29 US$1,004
2022-05-23 2022-05-20
US Oragenics Inc (OGEN)
B Purchase
65,718 +7.7%
0.28
US$18,638 		65,718 +7.7% 0.28 US$18,638
2022-05-20 2022-05-19
US Oragenics Inc (OGEN)
B Purchase
56,806 +7.1%
0.28
US$15,945 		56,806 +7.1% 0.28 US$15,945
2022-05-20 2022-05-18
US Oragenics Inc (OGEN)
B Purchase
15,303 +2.0%
0.26
US$3,994 		15,303 +2.0% 0.26 US$3,994
2022-04-01 2022-03-31
US Oragenics Inc (OGEN)
B Purchase
59,053 +8.2%
0.35
US$20,769 		59,053 +8.2% 0.35 US$20,769
2022-04-01 2022-03-30
US Oragenics Inc (OGEN)
B Purchase
124,785 +20.9%
0.36
US$45,284 		124,785 +20.9% 0.36 US$45,284
2020-11-25 2020-11-24
US Oragenics Inc (OGEN)
B Purchase
100,000 +29.5%
0.37
US$37,000 		100,000 +29.5% 0.37 US$37,000
2019-03-27 2019-03-25
US Oragenics Inc (OGEN)
B Purchase
100,000
0.00
US$0 		100,000 0.00 US$0